Top 5 Otome Games Performance in Austria Q3 2023

In the third quarter of 2023, the top 5 Otome games in Austria showed varied performance in terms of weekly downloads, revenue, and active users on a unified platform. Here’s a closer look at each app's metrics:

Blood Kiss: Vampire story, published by StoryTaco.inc, saw a notable increase in weekly revenue towards the end of the quarter, peaking at around $105 in the week of September 11. Weekly downloads fluctuated, with a significant spike to 55 in mid-July and another surge to 40 in late September. Active users experienced a dip mid-quarter, dropping to 13, but recovered to 52 by the end of September.

Obey Me! Anime Otome Sim Game from NTT SOLMARE CORPORATION maintained a relatively steady weekly revenue, generally ranging between $105 and $257 throughout the quarter. Downloads remained low, with a slight peak of 22 in early August. Active users gradually declined from 280 at the start of the quarter to 181 by the end of September.

Blood in Roses - Otome Game, also by NTT SOLMARE CORPORATION, had minimal revenue generation, with occasional small peaks such as $20 in late July. Weekly downloads were modest, averaging around 13 to 19 downloads per week. Active user data was sparse, with notable activity only at the start and end of the quarter.

Love Story ® Romance Games by Webelinx Games showed a stable revenue stream, with weekly earnings fluctuating between $41 and $131. Downloads picked up significantly in September, reaching 57 in mid-September. Active users grew steadily, peaking at 100 in the last week of September, up from 51 at the beginning of the quarter.

Guard me, Sherlock! - otome, another title by NTT SOLMARE CORPORATION, had sporadic revenue with a notable peak of $118 in early July. Weekly downloads varied, with initial highs of 29 in early July and a low of 2 in early September. Active users showed some fluctuation, with a peak of 28 in late July and a drop to 10 by the end of September.

For more detailed insights and data, visit Sensor Tower.